Mirae Asset Global Investments Co., Ltd. Amphastar Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,609 shares of AMPH stock, worth $40,836. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,609
Previous 1,602
0.44%
Holding current value
$40,836
Previous $59,000
22.03%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AMPH
# of Institutions
258Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$151 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$61.5 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$56.1 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$40.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$34.4 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.24B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...